Adequate assessment yields appropriate care—the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working Group

Autor: Loh, K.P., Liposits, G., Arora, S.P., Neuendorff, N.R., Gomes, F., Krok-Schoen, J.L., Amaral, T., Mariamidze, E., Biganzoli, L., Brain, E., Baldini, C., Battisti, N.M.L., Frélaut, M., Kanesvaran, R., Mislang, A.R.A., Papamichael, D., Steer, C., Rostoft, S.

Publikováno v: In ESMO Open August 2024 9(8)

Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08-02 study.

Autor: Gendarme S; Univ Paris Est Creteil, INSERM, IMRB (CEpiA Team), F-94010 Creteil, France; Centre Hospitalier Intercommunal de Créteil, Service de Pneumologie, 40 avenue de Verdun, 94010 Créteil, France. Electronic address: sebastien.gendarme@u-pec.fr., Zebachi S; Univ Paris Est Creteil, INSERM, IMRB (CEpiA Team), F-94010 Creteil, France; Assistance Publique-Hôpitaux de Paris, Hôpital Henri-Mondor, Service de Santé Publique et Unité de Recherche Clinique, 1 Rue Gustave Eiffel, 94010 Créteil, France., Corre R; Centre Hospitalier Intercommunal de Cornouaille, Service de Pneumologie, 14 Av. Yves Thépot, 29000 Quimper, France., Greillier L; Aix-Marseille Université, AP-HM, INSERM, CNRS, CRCM, Hôpital Nord, Service d'Oncologie Multidisciplinaire et Innovations Thérapeutiques, Marseille, France., Justeau G; CHU d'Angers, Service de Pneumologie, 4 Rue Larrey, 49100 Angers, France., Bylicki O; HIA Sainte-Anne, Service de Pneumologie, 2, boulevard Saint-Anne, 83000 Toulon, France., Decroisette C; CH d'Annecy, Service de Pneumologie, 1, avenue de l'Hôpital, Metz-Tessy, 74374 Annecy, France., Auliac JB; Centre Hospitalier Intercommunal de Créteil, Service de Pneumologie, 40 avenue de Verdun, 94010 Créteil, France., Guisier F; Univ Rouen Normandie, LITIS Lab QuantIF team EA4108, CHU Rouen, France; Department of Pulmonology, Thoracic Oncology, and Respiratory Intensive Care & CIC-CRB INSERM 1404 F, 76000, Rouen, France., Geier M; CHU Morvan, Service de Pneumologie, 2, avenue Foch, 29200 Brest, France., Ricordel C; CHU Rennes, Service de Pneumologie, 2 Rue Henri le Guilloux, 35033 Rennes, France., Frelaut M; Gustave Roussy, Département d'Oncologie Médicale, 39 rue Camille-Desmoulins, 94805 Villejuif Cedex, France., Paillaud E; Univ Paris Est Creteil, INSERM, IMRB (CEpiA Team), F-94010 Creteil, France; Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Service de Gériatrie, 20, rue Leblanc, 75908 Paris Cedex 15, France., Chouaïd C; Univ Paris Est Creteil, INSERM, IMRB (CEpiA Team), F-94010 Creteil, France; Centre Hospitalier Intercommunal de Créteil, Service de Pneumologie, 40 avenue de Verdun, 94010 Créteil, France., Canouï-Poitrine F; Univ Paris Est Creteil, INSERM, IMRB (CEpiA Team), F-94010 Creteil, France; Assistance Publique-Hôpitaux de Paris, Hôpital Henri-Mondor, Service de Santé Publique et Unité de Recherche Clinique, 1 Rue Gustave Eiffel, 94010 Créteil, France.

Publikováno v: Journal of geriatric oncology [J Geriatr Oncol] 2024 Jul; Vol. 15 (6), pp. 101506. Date of Electronic Publication: 2023 May 19.

Prognostic impact of neurocognitive disorders in older patients with cancer: the ELCAPA prospective cohort study.

Autor: Conti C; AP-HP, Paris Cancer Institute CARPEM, Hôpital Européen Georges Pompidou, Department of Geriatrics, F-75015 Paris, France; Université Paris-Est, Inserm, 7376- IMRB, F-94000 Créteil, France. Electronic address: catherine.conti@aphp.fr., Paillaud E; AP-HP, Paris Cancer Institute CARPEM, Hôpital Européen Georges Pompidou, Department of Geriatrics, F-75015 Paris, France; Université Paris-Est, Inserm, 7376- IMRB, F-94000 Créteil, France., Laurent M; Université Paris-Est, Inserm, 7376- IMRB, F-94000 Créteil, France; AP-HP, Hopital Henri-Mondor, Department of Internal Medicine and Geriatrics, F-94010 Creteil, France., Poisson J; AP-HP, Paris Cancer Institute CARPEM, Hôpital Européen Georges Pompidou, Department of Geriatrics, F-75015 Paris, France; Université Paris-Cité, Center for Research on Inflammation, Inserm U1149, F-75018 Paris, France., Boudou-Rouquette P; AP-HP, Hôpital Cochin - Port-Royal, Department of Oncology, F-75014 Paris, France., Frelaut M; Gustave Roussy Cancer Campus, F-94076 Villejuif, France., Gay P; AP-HP, Paris Cancer Institute CARPEM, Hôpital Européen Georges Pompidou, Department of Geriatrics, F-75015 Paris, France., Canovas J; AP-HP, Paris Cancer Institute CARPEM, Hôpital Européen Georges Pompidou, Department of Geriatrics, F-75015 Paris, France., Caillet P; AP-HP, Paris Cancer Institute CARPEM, Hôpital Européen Georges Pompidou, Department of Geriatrics, F-75015 Paris, France; Université Paris-Est, Inserm, 7376- IMRB, F-94000 Créteil, France., Mebarki S; AP-HP, Paris Cancer Institute CARPEM, Hôpital Européen Georges Pompidou, Department of Geriatrics, F-75015 Paris, France., Broussier A; Université Paris-Est, Inserm, 7376- IMRB, F-94000 Créteil, France; AP-HP, Hôpitaux Henri-Mondor/Emile Roux, Department of Geriatrics, F-94456 Limeil-Brevannes, F-94000 Créteil, France., Canouï-Poitrine F; Université Paris-Est, Inserm, 7376- IMRB, F-94000 Créteil, France; AP-HP, Hopital Henri-Mondor, Public Health Departement, F-94010 Creteil, France.

Publikováno v: The journal of nutrition, health & aging [J Nutr Health Aging] 2024 May; Vol. 28 (5), pp. 100215. Date of Electronic Publication: 2024 Mar 21.

80P Tumor microenvironment (TME) defines prognosis of EGFR-mutant non-small cell lung cancer (NSCLC)

Autor: Zullo, L., Ghigna, M.R., Zrafi, W.S., Marinello, A., Vasseur, D., Frelaut, M., Abdayem, P., Tagliamento, M., Lavaud, P., Gazzah, A., Friboulet, L., Scoazec, J-Y., Remon, J., Barlesi, F., Besse, B., Planchard, D., Aldea, M.

Publikováno v: In ESMO Open October 2023 8(1) Supplement 5

Antibody drug conjugates in older patients: State of the art.

Autor: Rached L; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: layalerached@hotmail.com., Geraud A; Gustave Roussy, Department of Medical Oncology , 94805 Villejuif, France. Electronic address: Arthur.GERAUD@gustaveroussy.fr., Frelaut M; Gustave Roussy, Department of Medical Oncology , 94805 Villejuif, France. Electronic address: Maxime.FRELAUT@gustaveroussy.fr., Ap Thomas Z; Gustave Roussy, Department of Medical Oncology , 94805 Villejuif, France. Electronic address: Zoe.AP-THOMAS@gustaveroussy.fr., Goldschmidt V; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: Vincent.GOLDSCHMIDT@gustaveroussy.fr., Beraud-Chaulet G; Gustave Roussy, Department of Medical Oncology , 94805 Villejuif, France. Electronic address: Geoffroy.BERAUD-CHAULET@gustaveroussy.fr., Nagera-Lazarovici C; Gustave Roussy, Department of Medical Oncology , 94805 Villejuif, France. Electronic address: Celine.LAZAROVICI-NAGERA@gustaveroussy.fr., Danlos FX; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: FRANCOIS-XAVIER.DANLOS@gustaveroussy.fr., Henon C; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: Clemence.HENON@gustaveroussy.fr., Parisi C; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: Claudia.PARISI@gustaveroussy.fr., Gazzah A; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: Anas.GAZZAH@gustaveroussy.fr., Bahleda R; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: Rastilav.BAHLEDA@gustaveroussy.fr., Postel Vinay S; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: SOPHIE.POSTEL-VINAY@gustaveroussy.fr., Smolenschi C; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: Cristina.SMOLENSCHI@gustaveroussy.fr., Hollebecque A; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: Antoine.HOLLEBECQUE@gustaveroussy.fr., Michot JM; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: JEAN-MARIE.MICHOT@gustaveroussy.fr., Ribrag V; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: Vincent.RIBRAG@gustaveroussy.fr., Loriot Y; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: Yohann.LORIOT@gustaveroussy.fr., Champiat S; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: Stephane.CHAMPIAT@gustaveroussy.fr., Ouali K; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: Kaissa.OUALI@gustaveroussy.fr., Massard C; Centre Eugène Marquis, Department of Medical Oncology, 35000 Rennes, France. Electronic address: c.massard@rennes.unicancer.fr., Ponce Aix S; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: Santiago.PONCE@gustaveroussy.fr., Bringuier M; Institut Curie, PSL Research University, Department of Medical Oncology and Department of Supportive Care, UCOG Paris Ouest, F-92210 Saint-Cloud, France. Electronic address: michael.bringuier@curie.fr., Baldini C; Gustave Roussy, Department of Therapeutic Innovation and Early Phase Trials, 94805 Villejuif, France. Electronic address: Capucine.BALDINI@gustaveroussy.fr.

Publikováno v: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Jan; Vol. 193, pp. 104212. Date of Electronic Publication: 2023 Nov 24.